Marketable Securities	6 Months Ended
Jun. 30, 2022
Marketable Securities.
Marketable Securities	Note 3 – Marketable Securities Our marketable securities consist of equity securities classified as available-for-sale (“AFS”). AFS securities are carried at fair value on the condensed consolidated balance sheets. Unrealized gains and losses are reported in earnings within “other income (expense), net”. The specific identification method is used to determine realized gains and losses on AFS securities. During the three months and six months ended June 30, 2022, we purchased $3.8 million and $6.0 million of marketable equity securities, respectively. As of June 30, 2022, gross unrealized gains were $381 thousand, and gross unrealized losses were $0. As of June 30, 2022, our position in marketable equity securities had a historical cost of $6.0 million and a fair value of $6.4 million, as determined using Level 1 inputs on the fair value hierarchy.

Marketable Securities

6 Months Ended

Jun. 30, 2022

Note 3 – Marketable Securities

Our marketable securities consist of equity securities classified as available-for-sale (“AFS”). AFS securities are carried at fair value on the condensed consolidated balance sheets. Unrealized gains and losses are reported in earnings within “other income (expense), net”. The specific identification method is used to determine realized gains and losses on AFS securities. During the three months and six months ended June 30, 2022, we purchased $3.8 million and $6.0 million of marketable equity securities, respectively. As of June 30, 2022, gross unrealized gains were $381 thousand, and gross unrealized losses were $0. As of June 30, 2022, our position in marketable equity securities had a historical cost of $6.0 million and a fair value of $6.4 million, as determined using Level 1 inputs on the fair value hierarchy.